Press Releases

NANAIMO, British Columbia --(BUSINESS WIRE)--Apr. 16, 2021-- Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the Tilray board of directors approved an amendment to the Company’s bylaws to reduce the quorum

NANAIMO, British Columbia --(BUSINESS WIRE)--Apr. 15, 2021-- Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the special meeting of Tilray stockholders (the “ Tilray Special Meeting ”) scheduled for Friday, April

NANAIMO, British Columbia --(BUSINESS WIRE)--Apr. 12, 2021-- Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today reminds that holders (the “ Shareholders ”) of Tilray common shares (the “ Shares ”) vote FOR the proposals to complete

NANAIMO, British Columbia --(BUSINESS WIRE)--Apr. 5, 2021-- Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced both Institutional Shareholder Services Inc. (“ ISS ”) and Glass Lewis and Co., LLC (“ Glass Lewis ”) have

Tilray to Host Special Meeting of Stockholders on Friday, April 16, 2021 to Approve Proposed Aphria-Tilray Business Combination Proxy Materials Mailed to Aphria Shareholders and Tilray Stockholders of Record as of Friday, March 12, 2021   Required Regulatory Approvals Contemplated Under the

The Ministry of Health and the Medicinal Cannabis Agency of New Zealand grant Tilray the first approval under the new Medical Cannabis Scheme to launch medical cannabis products across the country NANAIMO, British Columbia --(BUSINESS WIRE)--Mar. 10, 2021-- Tilray, Inc .

Revenue Increased 26% to $210.5 Million in 2020 Compared to Prior Year Net Loss $(3.0) Million in Q4 2020 Versus Net Loss $(219.8) Million in Q4 2019 Achieved Adjusted EBITDA Goal With $2.2 Million in Q4 2020 Combination with Aphria Inc. Expected to Close in Q2 2021 to Create the World’s Largest

NANAIMO, British Columbia --(BUSINESS WIRE)--Feb. 12, 2021-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for 2020 full fiscal year and fourth quarter ended December

Grow Pharma will distribute Tilray’s GMP-certified medical cannabis products across the UK New UK agreement gives doctors and patients access to a sustainable supply of Tilray’s pharmaceutical-grade medical cannabis products NANAIMO, British Columbia --(BUSINESS WIRE)--Feb. 9, 2021-- Tilray Inc.

Worldpharma Biotech will produce the first medical cannabis products for clinical trials in Spain with Tilray GMP-certified medical cannabis Tilray medical cannabis will now be available in 17 countries around the world NANAIMO, British Columbia --(BUSINESS WIRE)--Feb. 4, 2021-- Tilray, Inc.